Feedback / Questions
risvodetinib (ABLi-148009) - ABLi Therapeutics
https://www.mdsabstracts.org/abstract/a-phase-2-study-of-risvodetinib-in-untreated-parkinsons-disease/
M. Werner; C. Meyer; E. Mancino; C. Klint; J. Pellecchia; A. Mcgarry; K. Kieburtz; C. Olanow
Oct 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next